Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001737287-25-000003

EVP of R&D sold 27,199 shares at $1.78 ($48,414)

From the SEC's structured data for this filing

Trades in this filing

Roberts Zachary · EVP of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-21 Sale : show line 1 in the form −27,199 $1.78 $48,414 488,054 D
Open-market sales · 27,199 sh · avg $1.78 · $48,414
Loading xslF345X05/wk-form4_1737667821.xml…